William G. Kaelin's most recent trade in Lilly(Eli) & Co was a trade of 302 Common Stock done at an average price of $728.5 . Disclosure was reported to the exchange on Nov. 18, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Lilly(Eli) & Co | William G. Kaelin | Director | Grant, award, or other acquisition of securities at price $ 728.48 per share. | 18 Nov 2024 | 302 | 21,464 (0%) | 0% | 728.5 | 220,000 | Common Stock |
Lilly(Eli) & Co | William G. Kaelin | Director | Grant, award, or other acquisition of securities at price $ 597.60 per share. | 20 Nov 2023 | 335 | 21,026 (0%) | 0% | 597.6 | 200,196 | Common Stock |
Lilly(Eli) & Co | William G. Kaelin | Director | Grant, award, or other acquisition of securities at price $ 361.17 per share. | 21 Nov 2022 | 498 | 20,470 (0%) | 0% | 361.2 | 179,863 | Common Stock |
Lilly(Eli) & Co | William G. Kaelin | Director | Grant, award, or other acquisition of securities at price $ 258.43 per share. | 15 Nov 2021 | 677 | 19,704 (0%) | 0% | 258.4 | 174,957 | Common Stock |
Lilly(Eli) & Co | William G. Kaelin | Director | Grant, award, or other acquisition of securities at price $ 140.59 per share. | 16 Nov 2020 | 1,245 | 18,730 (0%) | 0% | 140.6 | 175,035 | Common Stock |